Sodium-glucose cotransporter 2 inhibition, epidermal growth factor, and magnesium homeostasis: is there a link? Reply

被引：0
|
作者：
Ju, Wenjun [1 ,2 ]
Heerspink, Hiddo J. L. [3 ,4 ,7 ]
Kretzler, Matthias [1 ,2 ]
Bjornstad, Petter [5 ,6 ]
Bjornstad, Petter [5 ,6 ]
机构：
[1] Univ Michigan, Dept Internal Med, Div Nephrol, Ann Arbor, MI USA
[2] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI USA
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands
[4] Univ New South Wales, George Inst Global Hlth, Sydney, NSW, Australia
[5] Univ Colorado, Dept Pediat, Sect Endocrinol, Sch Med, Aurora, CO USA
[6] Univ Colorado, Dept Med, Div Renal Dis & Hypertens, Sch Med, Aurora, CO USA
[7] Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, De Brug 50C-1-011,AP50,POB 30001, NL-9700 AD Groningen, Netherlands
来源：
KIDNEY INTERNATIONAL | 2024年 / 105卷 / 03期
关键词：
D O I：
10.1016/j.kint.2023.10.033
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：639 / 639
页数：1
相关论文
共 50 条
  • [21] Sodium-Glucose Cotransporter 2 Inhibitors and Amputations
    Clements, Jennifer N.
    JAMA INTERNAL MEDICINE, 2019, 179 (03) : 451 - 452
  • [22] Sodium-glucose cotransporter 2 inhibition prevents renal fibrosis in cyclosporine nephropathy
    Castoldi, Giovanna
    Carletti, Raffaella
    Ippolito, Silvia
    Colzani, Massimiliano
    Barzaghi, Francesca
    Stella, Andrea
    Zerbini, Gianpaolo
    Perseghin, Gianluca
    Zatti, Giovanni
    di Gioia, Cira R. T.
    ACTA DIABETOLOGICA, 2021, 58 (08) : 1059 - 1070
  • [23] Re: Inhibition of Sodium-Glucose Cotransporter 2 Suppresses Renal Stone Formation
    Osther, Palle
    EUROPEAN UROLOGY, 2023, 84 (02) : 243 - 244
  • [24] Inhibition of sodium-glucose cotransporter 2 to slow the progression of chronic kidney disease
    Oguz, Fabie
    Demoulin, Nathalie
    Thissen, Jean Paul
    Jadoul, Michel
    Morelle, Johann
    ACTA CLINICA BELGICA, 2022, 77 (04) : 805 - 814
  • [25] Sodium-glucose cotransporter 2 inhibition in non-diabetic kidney disease
    Almaimani, Mohanad
    Sridhar, Vikas S.
    Cherney, David Z. I.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2021, 30 (05): : 474 - 481
  • [26] Sodium-glucose cotransporter-2 inhibition and renal function in clinical routine
    Kahl, Sabine
    DIABETOLOGE, 2020, 16 (02): : 192 - 194
  • [27] Sodium-glucose cotransporter 2 inhibition prevents renal fibrosis in cyclosporine nephropathy
    Giovanna Castoldi
    Raffaella Carletti
    Silvia Ippolito
    Massimiliano Colzani
    Francesca Barzaghi
    Andrea Stella
    Gianpaolo Zerbini
    Gianluca Perseghin
    Giovanni Zatti
    Cira R. T. di Gioia
    Acta Diabetologica, 2021, 58 : 1059 - 1070
  • [28] Renal sodium-glucose cotransporter inhibition in the management of type 2 diabetes mellitus
    Abdul-Ghani, Muhammad A.
    Norton, Luke
    DeFronzo, Ralph A.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2015, 309 (11) : F889 - F900
  • [29] Role of genetic variation in the human sodium-glucose cotransporter 2 gene (SGLT2) in glucose homeostasis
    Enigk, Uta
    Breitfeld, Jana
    Schleinitz, Dorit
    Dietrich, Kerstin
    Halbritter, Jan
    Fischer-Rosinsky, Antje
    Enigk, Beate
    Mueller, Ines
    Spranger, Joachim
    Pfeiffer, Andreas
    Stumvoll, Michael
    Kovacs, Peter
    Toenjes, Anke
    PHARMACOGENOMICS, 2011, 12 (08) : 1119 - 1126
  • [30] Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients
    Ferrannini, Ele
    Muscelli, Elza
    Frascerra, Silvia
    Baldi, Simona
    Mari, Andrea
    Heise, Tim
    Broedl, Uli C.
    Woerle, Hans-Juergen
    JOURNAL OF CLINICAL INVESTIGATION, 2014, 124 (02): : 499 - 508
12345